查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球腦圖設備市場，到 2030 年的預測：按產品類型、最終用戶和地區分類的全球分析
市場調查報告書
商品編碼
1371982

全球腦圖設備市場，到 2030 年的預測：按產品類型、最終用戶和地區分類的全球分析

Brain Mapping Instruments Market Forecasts to 2030 - Global Analysis By Product Type, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC預測，2023年全球腦圖設備市場規模將達25億美元，預計2030年將達到42億美元，預測期內年複合成長率為8.1%。

腦圖譜是切除腫瘤時檢測和保護關鍵大腦區域最準確的技術。對於腫瘤靠近大腦言語、運動或感覺部分的患者來說，這種手術可能是必要的。醫生可以盡可能切除腦腫瘤，同時盡量減少對控制運動、語言和感覺的大腦重要區域的影響。

根據世界衛生組織（WHO）2021年9月的最新資訊，2021年全球約有5500萬人患有失智症，每年報告的病例近1000萬例。

神經系統疾病增加

目標人口中神經系統疾病的流行意味著腦圖設備在醫療設備業的使用可能會更加迅速地擴大，為這些工具的市場創造了新的機會。此外，技術進步預計將導致全球幾家領先公司推出更多新產品，預計將對市場成長產生積極影響。

高成本

購買和維護腦圖設備（例如 MRI 掃描儀、腦電圖系統和腦磁圖機）的成本可能很高。這些設備的高成本可能是一個限制，特別是對於資金有限的醫療機構。設備成本可能會阻礙普及，特別是在資源有限的地區。

技術開發

隨著腦部影像和圖譜技術的不斷發展，腦圖譜設備市場潛力巨大。為了更準確地繪製大腦活動圖，功能性磁振造影(fMRI)、腦電圖 (EEG) 和腦磁圖 (MEG) 等新影像技術可提供更高的空間和時間解析度。此外，技術的發展導致繪製人腦圖的設備變得更加複雜和精確。這些技術提供了更強大的資料收集和分析能力、更高品質的影像以及改進的與其他系統和設備的通訊。這些進步使科學家和研究人員能夠更好地了解大腦如何運作、神經網路如何運作以及相關疾病如何運作。

無障礙問題

並非所有地方都能平等獲得腦圖設備，尤其是在農村和低收入國家。缺乏基礎設施，包括醫療設施和合格的工人，可能會限制腦圖設備的取得和使用。然而，有限的存取限制阻礙了這些技術的普遍普及，從而限制了市場的擴張。

COVID-19 的影響

COVID-19 是一場意想不到的全球公共衛生緊急事件，幾乎影響著所有企業。例如，根據 2021 年 12 月發表在《阿茲海默症期刊》上的一篇論文，COVID-19 不僅影響呼吸系統，還會引起神經和神經精神疾病。報告稱，該病毒會影響中樞神經系統（CNS），即使在 COVID-19 症狀消退後也可能導致認知障礙。結果，COVID-19 感染者的神經症狀惡化。於是就需要腦圖設備，這對疫情期間的市場拓展產生了重大影響。

預計在預測期內醫院部門將是最大的

由於住院患者數量的增加和主要市場參與企業推出的產品，醫院部門在預測期內佔據最大佔有率。此外，美國醫院數量的增加正在刺激市場擴張。根據美國心臟協會（AHA）2021年1月發布的數據，2021年美國投資者擁有的（營利性）社區醫院數量為1,228家，而州和地方地方政府醫院的數量為951家。此外，大量醫院產生對腦圖設備的需求，預計將推動市場擴張。

預計腦電圖 (EEG) 領域在預測期內年複合成長率最高

由於能夠使用影像技術診斷癲癇和癲癇等腦部疾病，腦電圖 (EEG) 領域預計在預測期內具有最高的年複合成長率。此外，腦電圖是一種有助於識別大腦電活動變化的診斷方法。因此，檢測各種大腦挑戰的快速應用進程正在推動市場擴張。

佔比最高的地區

由於美國神經系統疾病罹患率不斷上升、新技術接受度較早以及醫療基礎設施不斷加強，北美目前在全球腦圖設備市場佔據主導地位。例如，據阿茲海默症協會稱，2021年約有620萬65歲以上的美國將患有阿茲海默失智症，預計到2050年這一數字將上升至1,270萬。此外，高度發展的醫療保健系統和對研發的重視為該地區最尖端科技的實施提供了有利的環境。這些因素正在推動該地區的成長。

複合年複合成長率最高的地區

由於健康問題日益嚴重和最尖端科技的日益採用，預計亞太地區將在預測期內快速擴張。 NCBI 報告稱，該地區神經系統疾病的患病正在增加，導致大腦結構和認知功能的影像研究增加。此外，平面回波成像 (EPI) 等新方法正在用於治療腦部疾病患者。快速磁振造影技術（EPI）可以在很短的時間內取得磁振造影影像。因此，腦部疾病的流行和該地區最尖端科技的採用正在推動市場擴張。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究來源
    • 主要研究來源
    • 二次研究來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球腦圖譜設備市場：依產品類型

  • 磁振造影(MRI)
  • 近紅外線光光譜 (NIRS)
  • 腦電圖（EEG）
  • 正子斷層掃描 (PET)
  • CT檢查
  • 其他產品類型

第6章 全球腦圖譜設備市場：依最終用戶分類

  • 門診中心
  • 醫院
  • 其他最終用戶

第7章 全球腦圖譜設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第8章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • Advanced Brain Monitoring, Inc
  • Artinis Medical Systems
  • Canon Medical Systems Corp
  • General Electric Company
  • Gowerlabs Ltd
  • Koninklijke Philips NV
  • Medtronic
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • NIRx Medical Technologies, LLC
  • Siemens Healthcare Private Limited
  • Soterix Medical Inc
Product Code: SMRC24038

According to Stratistics MRC, the Global Brain Mapping Instruments Market is accounted for $2.5 billion in 2023 and is expected to reach $4.2 billion by 2030 growing at a CAGR of 8.1% during the forecast period. The most accurate technique to detect and safeguard important brain regions while removing a tumor is through brain mapping. This operation may be necessary for patients whose tumors are close to the linguistic, motor, or sensory parts of the brain. Doctors have been able to remove as much of a brain tumor as feasible while limiting the effect on the vital regions of the brain that regulate movement, speech, and the senses.

According to the September 2021 update by the World Health Organization (WHO), about 55 million people worldwide were living with dementia in 2021, and nearly 10 million cases are reported every year.

Market Dynamics:

Driver:

Increase in neurological conditions

The prevalence of neurological disorders among the target population means that the use of brain mapping instruments in the medical device industry is likely to grow more rapidly, opening up new opportunities for the market for these tools. Additionally, the increased introduction of new products by several major players globally as a result of enhanced technology is anticipated to positively affect market growth.

Restraint:

High costs

The cost of purchasing and maintaining brain mapping equipment like MRI scanners, EEG systems, and MEG devices can be high. These instruments' high costs can be a constraint, especially for healthcare facilities with limited funds. The cost of the tools may prevent their widespread use, particularly in areas with limited resources.

Opportunity:

Technological development

The market for brain mapping instruments has a lot of potential due to the ongoing developments in brain imaging and mapping technology. In order to map brain activity more precisely, new imaging techniques, including functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and magnetoencephalography (MEG), offer greater spatial and temporal resolution. Additionally, technology development has produced more complex and precise instruments for mapping the human brain. These technologies provide better data collection and analysis capacities, higher-quality images, and improved communication with other systems and devices. These advancements offer scientists and researchers a better understanding of how the brain works, how neural networks work, and how related illnesses work.

Threat:

Accessibility issues

Not all locations have equal access to brain mapping instruments, particularly rural and low-income nations. The accessibility and availability of brain mapping tools may be constrained by a lack of infrastructure, including healthcare facilities and competent workers. However, as it prevents the general adoption of these technologies, this restricted accessibility limits market expansion.

COVID-19 Impact:

An unexpected global public health emergency, COVID-19, has had an impact on practically every business. For instance, COVID-19 not only affects the respiratory system but also causes neurological and neuropsychiatric diseases, according to an article published in the Journal of Alzheimer's Diseases in December 2021. According to this, the virus may have an impact on the central nervous system (CNS), which could lead to cognitive impairment even after COVID-19 symptoms have subsided. As a result, people with COVID-19 developed worse neurological conditions. As a result, there was a need for brain mapping instruments, which had a major effect on market expansion during the epidemic.

The hospitals segment is expected to be the largest during the forecast period

Due to a rise in hospital admissions and product launches by the major market participants, the hospital segment dominated the largest share over the forecast period. The expansion of the market is also being fueled by the rising number of hospitals in the United States. According to numbers from the American Heart Association (AHA) released in January 2021, there were 1,228 investor-owned (for-profit) community hospitals in the United States in 2021, compared to 951 state and local government community hospitals. Moreover, the demand for brain mapping instruments is generated by the enormous number of hospitals, which is anticipated to fuel market expansion.

The Electroencephalography (EEG) segment is expected to have the highest CAGR during the forecast period

Due to its capabilities of using imaging techniques to diagnose brain illnesses, including epilepsy and seizures, the electroencephalography (EEG) segment is anticipated to have the highest CAGR throughout the projection period. Moreover, it is a method of diagnosis that aids in identifying alterations in the electrical activity of the brain. Therefore, it is promoting market expansion due to its quicker application process for detecting various brain challenges.

Region with largest share:

Due to the rising incidence of neurological illnesses, early acceptance of new technologies, and enhanced healthcare infrastructure in the US, North America currently holds a dominant position in the global market for brain mapping instruments. For instance, according to the Alzheimer's Association, in 2021, there were around 6.2 million Americans 65 and older who had Alzheimer's dementia, and that number is predicted to rise to 12.7 million by the year 2050. Moreover, the highly developed healthcare system and concentration on research and development provide a climate that is favorable to the adoption of cutting-edge technologies in the region. These elements are boosting the region's growth.

Region with highest CAGR:

Owing to growing health concerns and increased adoption of cutting-edge technologies, Asia-Pacific is anticipated to expand at a rapid pace over the course of the projected period. The NCBI reports that the rising prevalence of neurological illnesses in the area has led to an increase in neuroimaging investigations of brain structure and cognitive functioning. The treatment of individuals with brain illnesses has also adapted new methods, such as echo-planar imaging (EPI). The rapid MRI technique known as EPI can acquire MR images in a very short amount of time. As a result, the prevalence of brain illnesses and the adoption of cutting-edge technologies in the region have fueled market expansion.

Key players in the market:

Some of the key players in Brain Mapping Instruments market include: Advanced Brain Monitoring, Inc, Artinis Medical Systems, Canon Medical Systems Corp, General Electric Company, Gowerlabs Ltd, Koninklijke Philips N.V., Medtronic, Natus Medical Incorporated, Nihon Kohden Corporation, NIRx Medical Technologies, LLC, Siemens Healthcare Private Limited and Soterix Medical Inc.

Key Developments:

In September 2022, Scientists at the Allen Institute established the Brain Genome Project, a new global partnership to map approximately 200 billion cells in the human brain by type and function.

In March 2022, Kernel, a neurotechnology company, developed a wearable headset device, Kernel Flow, for brain measurement, which is based on time-domain functional near-infrared spectroscopy (TD-fNIRS). The device enables accurate, high-resolution measurement of the brain, and it functions by emitting picosecond pulses of light into tissue and measuring the arrival times of single photons.

Product Types Covered:

  • Magnetic Resonance Imaging (MRI)
  • Near-Infrared Spectroscopy (NIRS)
  • Electroencephalography (EEG)
  • Positron Emission Tomography (PET)
  • Computed Tomography
  • Other Product Types

End Users Covered:

  • Ambulatory Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain Mapping Instruments Market, By Product Type

  • 5.1 Introduction
  • 5.2 Magnetic Resonance Imaging (MRI)
  • 5.3 Near-Infrared Spectroscopy (NIRS)
  • 5.4 Electroencephalography (EEG)
  • 5.5 Positron Emission Tomography (PET)
  • 5.6 Computed Tomography
  • 5.7 Other Product Types

6 Global Brain Mapping Instruments Market, By End User

  • 6.1 Introduction
  • 6.2 Ambulatory Centers
  • 6.3 Hospitals
  • 6.8 Other End Users

7 Global Brain Mapping Instruments Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Advanced Brain Monitoring, Inc
  • 9.2 Artinis Medical Systems
  • 9.3 Canon Medical Systems Corp
  • 9.4 General Electric Company
  • 9.5 Gowerlabs Ltd
  • 9.6 Koninklijke Philips N.V.
  • 9.7 Medtronic
  • 9.8 Natus Medical Incorporated
  • 9.9 Nihon Kohden Corporation
  • 9.10 NIRx Medical Technologies, LLC
  • 9.11 Siemens Healthcare Private Limited
  • 9.12 Soterix Medical Inc

List of Tables

  • Table 1 Global Brain Mapping Instruments Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 4 Global Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 5 Global Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 6 Global Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 7 Global Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 8 Global Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 9 Global Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 10 Global Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 11 Global Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 12 Global Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 13 North America Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 14 North America Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 15 North America Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 16 North America Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 17 North America Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 18 North America Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 19 North America Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 20 North America Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 21 North America Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 North America Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 23 North America Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 North America Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 Europe Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 Europe Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 Europe Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 28 Europe Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 29 Europe Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 30 Europe Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 31 Europe Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 32 Europe Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 33 Europe Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 34 Europe Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 35 Europe Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 36 Europe Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 37 Asia Pacific Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 38 Asia Pacific Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 39 Asia Pacific Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 40 Asia Pacific Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 41 Asia Pacific Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 42 Asia Pacific Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 43 Asia Pacific Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 44 Asia Pacific Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 45 Asia Pacific Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Asia Pacific Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 47 Asia Pacific Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 48 Asia Pacific Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 South America Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 South America Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 South America Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 52 South America Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 53 South America Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 54 South America Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 55 South America Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 56 South America Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 57 South America Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 South America Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 59 South America Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 South America Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Middle East & Africa Brain Mapping Instruments Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Middle East & Africa Brain Mapping Instruments Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 Middle East & Africa Brain Mapping Instruments Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
  • Table 64 Middle East & Africa Brain Mapping Instruments Market Outlook, By Near-Infrared Spectroscopy (NIRS) (2021-2030) ($MN)
  • Table 65 Middle East & Africa Brain Mapping Instruments Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 66 Middle East & Africa Brain Mapping Instruments Market Outlook, By Positron Emission Tomography (PET) (2021-2030) ($MN)
  • Table 67 Middle East & Africa Brain Mapping Instruments Market Outlook, By Computed Tomography (2021-2030) ($MN)
  • Table 68 Middle East & Africa Brain Mapping Instruments Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 69 Middle East & Africa Brain Mapping Instruments Market Outlook, By End User (2021-2030) ($MN)
  • Table 70 Middle East & Africa Brain Mapping Instruments Market Outlook, By Ambulatory Centers (2021-2030) ($MN)
  • Table 71 Middle East & Africa Brain Mapping Instruments Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 72 Middle East & Africa Brain Mapping Instruments Market Outlook, By Other End Users (2021-2030) ($MN)